These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32849249)

  • 41. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does nutritional status affect Parkinson's Disease features and quality of life?
    Ongun N
    PLoS One; 2018; 13(10):e0205100. PubMed ID: 30278074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.
    Xu W; Zhi Y; Yuan Y; Zhang B; Shen Y; Zhang H; Zhang K; Xu Y
    J Neural Transm (Vienna); 2018 Jul; 125(7):1027-1032. PubMed ID: 29748849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcranial sonography in depression.
    Mijajlovic MD
    Int Rev Neurobiol; 2010; 90():259-72. PubMed ID: 20692507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GBA-associated PD presents with nonmotor characteristics.
    Brockmann K; Srulijes K; Hauser AK; Schulte C; Csoti I; Gasser T; Berg D
    Neurology; 2011 Jul; 77(3):276-80. PubMed ID: 21734182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
    Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
    Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of transcranial sonography-magnetic resonance fusion imaging in Wilson's and early-onset Parkinson's diseases.
    Mašková J; Školoudík D; Burgetová A; Fiala O; Brůha R; Záhoráková D; Serranová T; Slovák M; Ulmanová O; Růžička E; Dušek P
    Parkinsonism Relat Disord; 2016 Jul; 28():87-93. PubMed ID: 27147115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
    Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L
    Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An Investigation on the Clinical Features and Neurochemical Changes in Parkinson's Disease With Depression.
    Lian TH; Guo P; Zuo LJ; Hu Y; Yu SY; Liu L; Jin Z; Yu QJ; Wang RD; Li LX; Piao YS; Zhang W
    Front Psychiatry; 2018; 9():723. PubMed ID: 30713507
    [No Abstract]   [Full Text] [Related]  

  • 54. The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).
    He L; Lee EY; Sterling NW; Kong L; Lewis MM; Du G; Eslinger PJ; Huang X
    J Parkinsons Dis; 2016 May; 6(3):523-32. PubMed ID: 27258700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relation of sexual dysfunction to depression and anxiety in patients with Parkinson's disease.
    Özcan T; Benli E; Demir EY; Özer F; Kaya Y; Haytan CE
    Acta Neuropsychiatr; 2015 Feb; 27(1):33-7. PubMed ID: 25385451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study.
    Yu SY; Cao CJ; Zuo LJ; Chen ZJ; Lian TH; Wang F; Hu Y; Piao YS; Li LX; Guo P; Liu L; Yu QJ; Wang RD; Chan P; Chen SD; Wang XM; Zhang W
    BMC Neurol; 2018 Jan; 18(1):9. PubMed ID: 29343241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study.
    Becker G; Becker T; Struck M; Lindner A; Burzer K; Retz W; Bogdahn U; Beckmann H
    Biol Psychiatry; 1995 Aug; 38(3):180-4. PubMed ID: 7578661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.